Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NWL | Options (Right to Buy) | Award | $0 | +444K | +50% | $0.00 | 1.33M | Oct 2, 2022 | Common Stock | 444K | $17.79 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On October 2, 2019 (the "Grant Date"), the Reporting Person was granted an award of 1,333,333 options. The option award vested in three (3) equal installments on the 18 month, second and third anniversaries of the Grant Date after the satisfaction of the following performance condition: the Company's closing stock price (as reported on the Nasdaq Stock Exchange) for any 30 continuous calendar day period between the 18-calendar month and third anniversary of the Grant Date must exceed 125% of the closing stock price of the Company's common stock on July 29, 2019 (the "Performance Criteria"). As previously reported, the Performance Criteria were met and the first and second installments of 444,444 options each, have vested and became exercisable. The third installment, consisting of 444,445 options, vested and became exercisable on October 2, 2022. |
F2 | Options expire on the tenth anniversary of the Grant Date. If the Reporting Person's employment with the Company terminates due to death, disability or retirement, then the options shall continue to vest as stated above, and shall instead expire on the third anniversary of the later of the Reporting Person's: (1) termination of employment or (ii) applicable vesting date, provided that any such date shall occur prior to the tenth anniversary of the Grant Date. |